CD44 and acute kidney injury: Shen Z created a CD44-targeted and ROS-responsive CS-BR-mediated multifunctional liposome loading celastrol (CS-BR@CLT) for the targeted therapy of AKI, which exhibited multiple anti-AKI functions [278].